Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ABH HealthcareNSE:ABH +9.92%15 Debt-to-Equity is 3.58 as of Mar. 2025, which is 20% below its 10-year median of 4.47. GuruFocus rates NSE:ABH with a GF Score™ of 15/100. The stock has 2 warning signs investors should review. Among 565 Healthcare Providers & Services companies, ABH Healthcare ranks worse than 94.16% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for ABH Healthcare's Debt-to-Equity or its related term are showing as below:
NSE:ABH'
s Debt-to-Equity Range Over the Past 10 Years
Min: 3.18 Med: 4.47 Max: 111.47
Current: 3.18
During the past 4 years, the highest Debt-to-Equity Ratio of ABH Healthcare was 111.47. The lowest was 3.18. And the median was 4.47.
NSE:ABH's Debt-to-Equity is ranked worse than 94.16% of 565
companies
in the Healthcare Providers & Services industry
Industry Median: 0.43
vs NSE:ABH: 3.18
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
ABH Healthcare Debt-to-Equity Related Terms
ABH Healthcare Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for ABH Healthcare's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ABH Healthcare Debt-to-Equity Chart
ABH Healthcare Annual Data
Trend
Mar22
Mar23
Mar24
Mar25
Debt-to-Equity
111.47
4.47
5.06
3.58
ABH Healthcare Quarterly Data
Mar25
Debt-to-Equity
3.58
NSE:ABH vs : Debt-to-Equity Comparison
For the Medical Care Facilities subindustry, ABH Healthcare's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ABH Healthcare Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, ABH Healthcare's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where ABH Healthcare's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ABH Healthcare (NSE:ABH) has a Debt-to-Equity of 3.58 as of Mar. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on ABH Healthcare and its competitors. This is 20% below median its historical median of 4.47. Over the past decade, ABH Healthcare's Debt-to-Equity has ranged from 3.18 to 111.47. According to the industry distribution chart, ABH Healthcare ranks #532 out of 565 companies in the Healthcare Providers & Services industry, placing it in the top 94.2%.
Is ABH Healthcare's Debt-to-Equity too high?
ABH Healthcare's current Debt-to-Equity of 3.58 is 20% below median its 10-year median of 4.47. Over the past 10 years, this metric has ranged from a low of 3.18 to a high of 111.47. The Healthcare Providers & Services industry median Debt-to-Equity is 0.43. ABH Healthcare's value of 3.58 is 732.6% above this industry median. Based on the distribution chart, ABH Healthcare ranks #532 out of 565 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, ABH Healthcare has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does ABH Healthcare's Debt-to-Equity compare to ?
According to the Healthcare Providers & Services industry distribution chart, ABH Healthcare ranks #532 out of 565 companies for Debt-to-Equity. This places ABH Healthcare in the lower half of its industry. The industry median Debt-to-Equity is 0.43. ABH Healthcare's value of 3.58 is 732.6% above this benchmark. Historically, ABH Healthcare's own Debt-to-Equity has ranged from 3.18 to 111.47 over the past decade. While the company's 10-year median is 4.47 vs. the industry median of 0.43, ABH Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.43, based on 565 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ABH Healthcare's current Debt-to-Equity of 3.58 is 732.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on ABH Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ABH Healthcare's current Debt-to-Equity is 3.58, which is 20% below median its own 10-year median of 4.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ABH Healthcare stock overvalued right now?
ABH Healthcare (NSE:ABH) has a current Debt-to-Equity of 3.58. The current Debt-to-Equity is 3.58, which is 20% below median its 10-year median of 4.47 and 732.6% above the Healthcare Providers & Services industry median of 0.43. ABH Healthcare's overall GF Score™ is 15/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For ABH Healthcare (NSE:ABH), the current Debt-to-Equity is 3.58 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
ABH Healthcare Ltd is engaged in the business of establishing, maintaining, and assisting healthcare services in India, in the form of Super Speciality Hospitals and allied services such as Laboratories & Diagnostic Centres, Blood Bank and other related services. Its medical services cover specialties such as cardiology, neurology, gastroenterology, urology, pulmonology, nephrology, obstetrics and gynecology, critical care, orthopedics, general and laparoscopic surgery, dentistry, physiotherapy, dermatology, and radiology. The company derives the majority of inpatient revenue from its internal medicine, cardiology, neurosurgery, and orthopedics / joint replacement/trauma services.
15GF Score
Get the complete analysis for NSE:ABH
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ABH has been successfully added to your 
